Cizzle Brands Launches CWENCH Hydration in 149 Locations of Loblaws, Zehrs and Real Canadian/Atlantic Superstore Biotech Investing
Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson's Disease Biotech Investing
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates Biotech Investing
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development Biotech Investing
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting Biotech Investing
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland Biotech Investing
Biogen Receives European Commission Approval for ZURZUVAE® , the First and Only Treatment Approved for Women with Postpartum Depression in Europe Biotech Investing
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025 Biotech Investing
Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery Biotech Investing
Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV's 8th AVG and 3rd IMRP 2025 Meeting Biotech Investing
